Investigator-initiated, open-label trial of ustekinumab for the treatment of moderate-to-severe palmoplantar psoriasis

Increased peripheral Th17 in patients with pustulosis palmaris et plantaris

(2011) Kan Torii et al.   ARCHIVES OF DERMATOLOGICAL RESEARCH

Recalcitrant Palmoplantar Pustular Psoriasis Treated with Etanercept

(2011) UXUA FLORISTAN et al.   PEDIATRIC DERMATOLOGY

Evaluation of topical 0.1% tazarotene cream in the treatment of palmoplantar psoriasis: An observer-blinded randomized controlled study

(2011) BijalH Mehta et al.   INDIAN JOURNAL OF DERMATOLOGY

Increased IL-23 Expression in Palmoplantar Psoriasis and Hyperkeratotic Hand Dermatitis

(2010) Joseph V. Lillis et al.   ARCHIVES OF DERMATOLOGY

Ustekinumab in the treatment of palmoplantar pustulosis

(2010) S. Gerdes et al.   BRITISH JOURNAL OF DERMATOLOGY

THERAPEUTIC HOTLINE: Alefacept in the treatment of hyperkeratotic palmoplantar psoriasis

(2010) Sagi Lior et al.   Dermatologic Therapy

Efficacy of Ustekinumab in Palmoplantar Psoriasis

(2010) C. Bulai Livideanu et al.   DERMATOLOGY

Pustulosis palmoplantaris is a disease distinct from psoriasis

(2010) Anne C. de Waal et al.   JOURNAL OF DERMATOLOGICAL TREATMENT

Can we really separate palmoplantar pustulosis from psoriasis?

(2010) AMG Brunasso et al.   JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY

What are the best outcome measures for assessing plaque psoriasis severity? A systematic review of the literature

(2010) E Puzenat et al.   JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY

Therapeutic options for palmoplantar pustulosis

(2009) E. Adişen et al.   CLINICAL AND EXPERIMENTAL DERMATOLOGY

Palmoplantar pustulosis treated with itraconazole: a single, active-arm pilot study

(2009) M. T. V'lckova-Laskoska et al.   Dermatologic Therapy

How Good Are Clinical Severity and Outcome Measures for Psoriasis?: Quantitative Evaluation in a Systematic Review

(2009) Phyllis I. Spuls et al.   JOURNAL OF INVESTIGATIVE DERMATOLOGY

Palmoplantar psoriasis: A phenotypical and clinical review with introduction of a new quality-of-life assessment tool

(2009) Elizabeth Farley et al.   JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY

Efalizumab for severe palmo-plantar psoriasis: an open-label pilot trial in five patients

(2009) AMG Brunasso et al.   JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY

Extra-palmoplantar lesions associated with palmoplantar pustulosis

(2009) T Yamamoto   JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY

A retrospective analysis of treatment responses of palmoplantar psoriasis in 114 patients

(2009) E Adışen et al.   JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY

Ustekinumab, a human interleukin 12/23 monoclonal antibody, for psoriatic arthritis: randomised, double-blind, placebo-controlled, crossover trial

(2009) Alice Gottlieb et al.   LANCET

Successful Treatment of Recalcitrant Palmoplantar Pustular Psoriasis with Sequential Use of Infliximab and Adalimumab

(2008) Nikhil Yawalkar et al.   DERMATOLOGY

Induction and exacerbation of psoriasis with TNF-blockade therapy: A review and analysis of 127 cases

(2008) Justin M. Ko et al.   JOURNAL OF DERMATOLOGICAL TREATMENT

Efficacy and safety of ustekinumab, a human interleukin-12/23 monoclonal antibody, in patients with psoriasis: 76-week results from a randomised, double-blind, placebo-controlled trial (PHOENIX 1)

(2008) Craig L Leonardi et al.   LANCET

Efficacy and safety of ustekinumab, a human interleukin-12/23 monoclonal antibody, in patients with psoriasis: 52-week results from a randomised, double-blind, placebo-controlled trial (PHOENIX 2)

(2008) Kim A Papp et al.   LANCET

Palmoplantar pustulosis should not be considered as a variant of psoriasis

(2007) A Ammoury et al.   JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY